Clin2
NCT06361238Possibly a fitRecruiting

Liraglutide to prevent confusion after heart surgery in seniors with diabetes

Delirium, Postoperative

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial is testing if liraglutide, a diabetes medication, can prevent delirium (sudden confusion) in older adults with type 2 diabetes who are having planned heart surgery. If you qualify, you may help find a new way to protect brain function after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
260 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You are 60 years old or older
  • You have type 2 diabetes
  • You are scheduled to have elective (non-emergency) heart surgery
  • You do not have serious kidney or liver disease, or a history of pancreatitis
  • You have not taken similar diabetes medications (like GLP-1s or SGLT2s) before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06788626Not yet recruiting· Phase 3
Testing a medication after clot removal for major stroke

This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.

Hefei, Anhui
NCT06324461Recruiting· Phase 4
GLP-1 drug to protect heart after non-emergency surgery

This study tests whether a GLP-1 receptor agonist (a medication used for diabetes and weight loss) can reduce heart damage during or after planned non-cardiac surgery. It may help patients with heart risk undergoing intermediate to high-risk procedures.

Hong Kong, Hong Kong SAR
NCT03087032Recruiting· Phase 4
Liraglutide injections vs insulin for uncontrolled type 2 diabetes

This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.

Xiamen, Fujian
NCT07511543Not yet recruiting· Phase 2
Studying a diabetes drug to improve recovery after stroke surgery

This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.

NCT06720246Recruiting
Weight loss surgery and liraglutide study on thinking and long-term weight

This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.

Milan, Milan
NCT03883412Recruiting· Phase 4
Exercise and liraglutide for type 2 diabetes

This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.

Charlottesville, Virginia

Hear when a new Delirium, Postoperative trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.